Putative adverse outcome pathways relevant to neurotoxicity.

Détails

ID Serval
serval:BIB_9D982FBE4F81
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Putative adverse outcome pathways relevant to neurotoxicity.
Périodique
Critical Reviews in Toxicology
Auteur(s)
Bal-Price A., Crofton K.M., Sachana M., Shafer T.J., Behl M., Forsby A., Hargreaves A., Landesmann B., Lein P.J., Louisse J., Monnet-Tschudi F., Paini A., Rolaki A., Schrattenholz A., Suñol C., van Thriel C., Whelan M., Fritsche E.
ISSN
1547-6898 (Electronic)
ISSN-L
1040-8444
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
45
Numéro
1
Pages
83-91
Langue
anglais
Notes
Publication types: Journal Article Publication Status: ppublish
Résumé
The Adverse Outcome Pathway (AOP) framework provides a template that facilitates understanding of complex biological systems and the pathways of toxicity that result in adverse outcomes (AOs). The AOP starts with an molecular initiating event (MIE) in which a chemical interacts with a biological target(s), followed by a sequential series of KEs, which are cellular, anatomical, and/or functional changes in biological processes, that ultimately result in an AO manifest in individual organisms and populations. It has been developed as a tool for a knowledge-based safety assessment that relies on understanding mechanisms of toxicity, rather than simply observing its adverse outcome. A large number of cellular and molecular processes are known to be crucial to proper development and function of the central (CNS) and peripheral nervous systems (PNS). However, there are relatively few examples of well-documented pathways that include causally linked MIEs and KEs that result in adverse outcomes in the CNS or PNS. As a first step in applying the AOP framework to adverse health outcomes associated with exposure to exogenous neurotoxic substances, the EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) organized a workshop (March 2013, Ispra, Italy) to identify potential AOPs relevant to neurotoxic and developmental neurotoxic outcomes. Although the AOPs outlined during the workshop are not fully described, they could serve as a basis for further, more detailed AOP development and evaluation that could be useful to support human health risk assessment in a variety of ways.
Pubmed
Web of science
Création de la notice
21/02/2015 14:00
Dernière modification de la notice
20/08/2019 15:03
Données d'usage